Novo Nordisk won FDA approval of its new FlexTouch insulin injection pens prefilled with either NovoLog (insulin aspart) or Levemir (insulin detemir). The FlexTouch features variable dose selection for anywhere between 1 and 80 units, while the button remains as easy to push for smaller injections as for larger ones. Each pen holds 300 units of insulin and is compatible with both NovoFine and the newer NovoTwist needles.
The new pens will be available in the U.S. next year and in Europe they’ve been approved since 2011.
source:Novo Nordisk
NovoNordisk NovoLog FlexTouch and Levemir FlexTouch Pen Injectors
